Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

By afschroeder • November 27, 2025

Khanna D, Spino C, Tashkin DP, Bernstein EJ, Goldin J, Kleerup EC, Harui A, Ibrahim G, Kim GHJ, Huang S, McLain R, Tu YH, Nagaraja V, Silver RM, Steen VD, Weigt SS, Lee JS, Fischer A, Scholand MB, Gordon JK, Dellaripa PF, Rosas IO, Hunninghake GM, Trojanowski MA, Simms RW, Dematte JE, Hsu VM, Domsic RT, Raghu G, Mayes MD, Boente RD, Roth MD; Scleroderma Lung Study III Investigators. Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis-Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. ACR Open Rheumatol. 2025 Dec;7(12):e70126. doi: 10.1002/acr2.70126. PMID: 41294296; PMCID: PMC12648624.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival

Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching PA, Bardia A, Chia S, Im SA, Martin M, Xu B, Barrios CH, Untch M, Moroose[...]

Obesity mortality on the rise: A 54-year US perspective

Aamir J, Afridi MK, Sajid M, Khan TM, Qureshi S, Ahmed R, Fonarow GC, Minhas AMK, Waqas SA. Obesity mortality on the rise: A 54-year[...]

Screening for Hepatocellular Carcinoma Recurrence After Liver Transplantation: Prospective Validation of Binary Criteria

Dixon W, Chandna S, Sack JS, Gray M, Brown CN, Poreddy S, Ha K, Schoech MR, Zucker SD. Screening for Hepatocellular Carcinoma Recurrence After Liver[...]